| Literature DB >> 32626746 |
Pavithra L Jayatilake1, Helani Munasinghe1.
Abstract
Endophytic and rhizosphere fungi are understood to be aiding the host plant to overcome a range of biotic and abiotic stresses (nutrition depletion, droughts, etc.) hence, they remain to be reservoirs of plethora of natural products with immense use. Consequently, this investigation of endophytic and rhizosphere fungi isolated from Mikania cordata (a perennial vine that is well established in Sri Lanka) for their antimicrobial properties was performed with the aim of future derivation of potential beneficial pharmaceutical products. Leaves, twigs, and roots of M. cordata were utilized to isolate a total of 9 endophytic fungi out of which the highest amount (44%) accounted was from the twigs. A sample of the immediate layer of soil adhering to the root of M. cordata was utilized to isolate 15 rhizosphere fungi. Fusarium equiseti and Phoma medicaginis were endophytes that were identified based on colony and molecular characteristics. The broad spectrum of antimicrobial activity depicted by F. equiseti (MK517551) was found to be significantly greater (p ≤ 0.05, inhibitory against Bacillus cereus ATCC 11778, Staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25922, and Pseudomonas aeruginosa ATCC 25853) than P. medicaginis (MK517550) (inhibitory against Staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25922, and Pseudomonas aeruginosa ATCC 25853) as assessed using the Kirby-Bauer disk diffusion method. Trichoderma virens and Trichoderma asperellum were rhizospere fungi that exhibited remarkable antimicrobial properties against the test pathogens chosen for the study. T. asperellum indicated significantly greater bioactivity against all four bacterial pathogens and Candida albicans ATCC 10231 under study. The ranges of minimum inhibitory concentrations (MICs) of the fungi depicting antimicrobial properties were determined. The results obtained suggest that F. equiseti, P. medicaginis, T. asperellum, and T. virens of M. cordata harness bioprospective values as natural drug candidates. This is the first report on isolation and evaluation of the antimicrobial properties of endophytic and rhizosphere fungi of Mikania cordata.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32626746 PMCID: PMC7315265 DOI: 10.1155/2020/5292571
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Preliminary screening of in vitro antimicrobial activity of isolated endophytic fungi against the selected test microorganisms by an agar plug diffusion assay performed on MHA (for bacterial pathogens) and SDA (for pathogenic yeasts) media, incubated at 37°C for 24 h. + = presence of a zone of inhibition; − = absence of a zone of inhibition.
| Isolated endophytic fungi | Test organism | ||||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| |
| MCEF001 |
|
|
|
|
|
|
|
| MCEF002 | + | + | + | + |
| + |
|
| MCEF003 | + |
|
|
|
|
|
|
| MCEF004 |
|
| + | + |
| + |
|
| MCEF005 |
| + |
| + |
|
|
|
| MCEF006 |
| + |
|
|
|
| + |
Screening of in vitro antimicrobial activity of metabolites extracted into the crude EA fraction from PDB of endophytic fungi performed on MHA (for bacterial pathogens) and SDA (for yeast pathogens).
| Test pathogenic organism | Mean diameter of the ZOI ± SD (mm) for crude EA extracts ( | Mean diameter of the ZOI ± SD (mm) for positive control ( | |||
|---|---|---|---|---|---|
|
|
| Chloramphenicol (30 | Gentamycin (10 | Ketoconazole (15 | |
|
| — | 20.3 ± 0.6B | 22 ± 0A | — | — |
|
| 16 ± 0B | 18 ± 1B | 28 ± 1A | — | — |
|
| 19.3 ± 0.6C | 20.7 ± 0.6B | — | 22 ± 0A | — |
|
| 17.1 ± 0.2C | 23 ± 0B | 30 ± 0A | ||
|
| 16 ± 1B | 16.7 ± 0.6B | — | — | 30 ± 0A |
Mean values sharing common letters in each row are not significantly different p ≤ 0.05.
Range of MIC determined for the crude EA extracts of the culture broths of endophytic fungi (P. medicaginis and F. equiseti) against human pathogenic microorganisms by the broth microdilution method performed at 37°C for 24 h.
| Test pathogenic organism | Range of MIC (mg/ml) | |
|---|---|---|
|
|
| |
|
| — | 0.35 > MIC > 0.15 |
|
| 1.0 > MIC > 0.45 | 0.35 > MIC > 0.15 |
|
| 1.0 > MIC > 0.45 | 0.35 > MIC > 0.15 |
|
| 1.0 > MIC > 0.45 | 0.35 > MIC > 0.15 |
|
| 1.0 > MIC > 0.45 | 1.5 > MIC > 0.35 |
Preliminary screening of in vitro antimicrobial activity of isolated rhizosphere fungi against the selected test microorganisms by the agar plug diffusion assay performed on MHA (for bacterial pathogens) and SDA (for pathogenic yeasts) media, incubated at 37°C for 24 h. + = presence of a zone of inhibition; − = absence of a zone of inhibition.
| Code numbers of the isolated rhizosphere fungi | Test organism | ||||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| |
| MCRF001 |
| − | − | − | − | − | − |
| MCRF003 | + | + | + | + | + | − | + |
| MCRF005 | − | − | + | − | − | + | − |
| MCRF006 | + | + | + | + | + | + | + |
| MCRF007 | − | + | − | − | − | − | + |
| MCRF009 | + | + | − | − | − | − | − |
In vitro screening of antimicrobial activity of metabolites extracted into the crude EA fraction from PDB of rhizosphere fungi performed on MHA (for bacterial pathogens) and SDA (for yeast pathogens).
| Test pathogenic organism | Mean diameter of the ZOI ± SD (mm) for crude EA extracts ( | Mean diameter of the ZOI ± SD (mm) for positive control ( | ||||
|---|---|---|---|---|---|---|
|
|
| Chloramphenicol (30 | Gentamycin (10 | Fluconazole (25 | Ketoconazole (15 | |
|
| 12.3 ± 0.6C | 17.6 ± 0.6B | 23 ± 1A | — | — | — |
|
| 22.8 ± 0.3B | 28 ± 1.7A | 30 ± 0A | — | — | — |
|
| 15.7 ± 1.2C | 18.7 ± 0.6B | — | 22 ± 0A | — | — |
|
| 15.3 ± 1.1C | 22.3 ± 0.6B | — | 30 ± 0A | — | — |
|
| 18.3 ± 0.6B | 13 ± 1C | — | — | 44 ± 0A | — |
|
| 15.3 ± 0.6B | 14 ± 1B | — | — | — | 30 ± 0A |
|
| — | 14 ± 0A | — | — | — | 27 ± 0B |
Mean values sharing common letters in each row are not significantly different p ≤ 0.05.
Range of MIC determined for the crude EA extracts of the culture broths of rhizosphere fungi against human pathogenic microorganisms by the broth microdilution method, incubated at 37°C for 24 h.
| Test pathogenic organism | Range of MIC (mg/ml) | |
|---|---|---|
|
|
| |
|
| 1.15 > MIC > 0.85 | 1.8 > MIC > 0.9 |
|
| 0.85 > MIC > 0.45 | 0.45 > MIC > 0.2 |
|
| 1.15 > MIC > 0.85 | 0.45 > MIC > 0.2 |
|
| 1.15 > MIC > 0.85 | 0.45 > MIC > 0.2 |
|
| 0.85 > MIC > 0.45 | 0.9 > MIC > 0.45 |